Twist Bioscience Corporation, a prominent player in the biotechnology sector, has been making significant strides in the field of synthetic DNA. Based in San Francisco, the company operates within the Health Care sector and specializes in a range of applications including biodetection, functional genomics, genome engineering, drug development, biodefense, and data storage. As of October 16, 2025, Twist Bioscience’s stock closed at $28.16 on the Nasdaq, where it has been publicly traded since its initial public offering on October 31, 2018.

The company’s market capitalization stands at approximately $1.7 billion, reflecting its substantial presence in the biotechnology industry. Over the past year, Twist Bioscience’s stock has experienced notable fluctuations, reaching a 52-week high of $55.33 on January 23, 2025, and a 52-week low of $24.07 on September 9, 2025. These variations highlight the dynamic nature of the biotechnology market and the company’s responsiveness to industry trends and investor sentiment.

Twist Bioscience’s core competency lies in its innovative approach to synthetic DNA technology. The company’s products and services cater to a diverse range of applications, from enhancing genomic research to advancing biodefense strategies. By leveraging its expertise in genome engineering, Twist Bioscience aims to address critical challenges in healthcare and beyond, offering solutions that are both cutting-edge and practical.

The company’s focus on functional genomics and biodetection underscores its commitment to improving patient outcomes and advancing scientific research. Through its efforts in drug development, Twist Bioscience is contributing to the creation of novel therapies that have the potential to transform the treatment landscape for various diseases. Additionally, the company’s work in data storage represents a forward-thinking approach to managing the ever-growing volume of genomic data, ensuring that valuable information is preserved and accessible for future research endeavors.

Twist Bioscience serves a broad patient base in the United States, providing access to its innovative technologies and solutions through its website, www.twistbioscience.com . As the company continues to expand its reach and impact, it remains dedicated to pushing the boundaries of synthetic DNA technology, driving progress in the biotechnology sector, and delivering tangible benefits to patients and researchers alike.